Review ArticleMonocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes
Highlights
► Historic perspectives of the pioneer studies on MCP-1. ► Role of MCP-1 in obesity-related metabolic syndrome. ► Role of MCP-1 in type 2 diabetes and diabetic complications. ► Treatments on MCP-1 over-production and inhibition of MCP-1 signaling.
Section snippets
Historical perspectives of Monocyte Chemoattractant Protein-1
1989 witnessed the birth of Monocyte Chemoattractant Protein-1 (MCP-1) into the light of scientific investigation at the National Cancer Institute, Maryland, USA. This protein was initially identified from the conditioned media of human myelomonocytic cell line as the monocyte chemotactic factor (MCF) [1]. It was further named as monocyte chemotactic and activating factor (MCAF), which was found to be rapidly produced in normal human dermal fibroblasts in response to the stimuli of
Transcriptional regulation of MCP-1
Expression of MCP-1 is ubiquitous in various cell types and is upregulated by a wide variety of stimuli. The list of MCP-1-producing cell types grew rapidly after the aforementioned pioneer studies in 1989 [13], [14], [15], [16], [17], [18]. A summary of MCP-1-producing cell types and stimuli can be found in Table 3 in a review by Van Collie et al. [8]. In addition, adipocytes have been recognized as an important source of MCP-1[19], [20].
Human MCP-1 gene consists of three exons of 145, 118 and
MCP-1 and obesity
A Pubmed keyword-guided literature search showed a linear increase of the number of publications related to “MCP-1” during the period of 1989–2010, while an exponential increase of the percentages of these publications pertaining to either “obesity” or “diabetes”, implicating a rapidly growing interest in the pathological role of this chemokine under obese and diabetic conditions.
Obesity is a result of expansion in both number and size of adipocytes. The gene expression of CC chemokines and
MCP-1 and type 2 diabetes
Type 2 diabetes comprises 95% of diabetic cases and its etiology is closely related to obesity and insulin resistance. Circulating MCP-1 has been found significantly increased in patients with type 2 diabetes [80], [81], [82], [83], [84].
A common A/G polymorphism located at position -2518 in the distal regulatory region regulates MCP-1 expression [85]. In a large cohort of German Caucasians, the MCP-1 G-2518 gene variant was found significantly and negatively correlated with plasma MCP-1 levels
Diabetic complication – cardiovascular disease
Diabetes is associated with accelerated rates of atherosclerosis. MCP-1 attracts monocytes to the inflammatory sites of vascular subendothelial space, initiating migration of monocytes into the arterial wall to form excessive macrophage-derived foam cells. Large population-based studies showed significant correlation between circulating MCP-1 and other traditional risk factor for atherosclerosis, such as serum high-sensitivity C-reactive protein (hsCRP), plasma fibrinogen, and combined carotid
Diabetic nephropathy
Diabetic nephropathy is a kidney disease that develops gradually over a period of 15–20 years after the onset of diabetes, affects ∼40% of diabetic patients, and is the primary cause of dialysis [138]. The pathologic abnormalities related to this diabetic complication include mesangial expansion, glomerular basement membrane thickening, and glomerular sclerosis [139]. The significant role of MCP-1 in the development of diabetic nephropathy has been implicated by several studies using MCP-1
Diabetic retinopathy
Diabetic retinopathy is a diabetic complication that can cause blindness. The incidence of this disease is approximately 60% after 10 years with type 1 diabetes and after 20 years with type 2 diabetes [192]. Reportedly myofibroblasts and vascular endothelial cells are the major cell types expressing MCP-1 in epiretinal membranes (ERMs), caused by changes in the vitreous humor in diabetic eyes [193]. When ERM were collected from patients with proliferative diabetic retinopathy (PDR), MCP-1 mRNA
Insulitis and islet transplantation
Insulitis is an inflammatory status in pancreatic islets, signified by mononuclear cell infiltration and destruction of insulin-producing cells. It is a causative factor of insulin dependence in both type 1 and type 2 diabetes [205]. In non-obese diabetic (NOD) mice, MCP-1 mRNA expression was found to increase with age and peak at the early phases of insulitis, and therefore the production of MCP-1 by cells could contribute to the recruitment of mononuclear cells into pancreatic islets [29].
MCP-1-specific treatments
Due to the pathological significance of MCP-1, efforts have been exerted to specifically target the signaling pathway of this chemokine. Several studies have attempted to decrease MCP-1 level in the circulation or block CCR2 activity by antibody administration. Such a neutralization of MCP-1 ameliorated glomerular crescent formation and development of interstitial fibrosis in mice [211]. However, when a MCP-1 monoclonal antibody was tested in patients with rheumatoid arthritis, the treatment
Acknowledgements
This study was made possible by Grant numbers R21 AT003874 and R21 AT005139 from NCCAM and ORWH, 5G12RR003061 (RCMI/BRIDGES), U54RR022762 (RTRN Small Grant Program), and 5P20RR016467 (INBRE II) from NCRR. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the funding agencies or the NIH.
References (225)
- et al.
Production of monocyte chemotactic and activating factor (MCAF) by human dermal fibroblasts in response to interleukin 1 or tumor necrosis factor
Biochem Biophys Res Commun
(1989) - et al.
Human monocyte chemoattractant protein-1 (MCP-1). Full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE
FEBS Lett
(1989) - et al.
Cloning and sequencing of the cDNA for human monocyte chemotactic and activating factor (MCAF)
Biochem Biophys Res Commun
(1989) - et al.
The MCP/eotaxin subfamily of CC chemokines
Cytokine Growth Factor Rev
(1999) - et al.
A YAC contig of the human CC chemokine genes clustered on chromosome 17q11.2
Genomics
(1996) - et al.
Organization and differential expression of the human monocyte chemoattractant protein 1 receptor gene. Evidence for the role of the carboxyl-terminal tail in receptor trafficking
J Biol Chem
(1997) - et al.
Alveolar macrophage-derived cytokines induce monocyte chemoattractant protein-1 expression from human pulmonary type II-like epithelial cells
J Biol Chem
(1991) - et al.
IL-1 receptor antagonist inhibits monocyte chemotactic peptide 1 generation by human mesangial cells
Kidney Int
(1992) - et al.
Regulation of monocyte chemoattractant protein-1 expression in adult human non-neoplastic astrocytes is sensitive to tumor necrosis factor(TNF) or antibody to the 55-kDa TNF receptor
J Neuroimmunol
(1994) - et al.
Structure of human monocyte chemotactic protein gene and its regulation by TPA
Biochem Biophys Res Commun
(1990)
Transcriptional regulation of the human monocyte chemoattractant protein-1 gene
J Biol Chem
Tumor necrosis factor-alpha induces expression of monocyte chemoattractant JE via fos and jun genes in clonal osteoblastic MC3T3-E1 cells
J Biol Chem
TNF regulates the in vivo occupancy of both distal and proximal regulatory regions of the murine monocyte chemoattractant protein-1 (MCP-1/JE) gene
Immunity
Conditioned medium from hypoxia-treated adipocytes renders muscle cells insulin resistant
Eur J Cell Biol
A novel role for the glucocorticoid receptor in the regulation of monocyte chemoattractant protein-1 mRNA stability
J Biol Chem
Visceral adiposity and the severity of coronary artery disease in middle-aged subjects with normal waist circumference and its relation with lipocalin-2 and MCP-1
Atherosclerosis
A low-glycemic index diet and exercise intervention reduces TNF(alpha) in isolated mononuclear cells of older, obese adults
J Nutr
MCP-1 (monocyte chemotactic protein-1)-induced protein, a recently identified zinc finger protein, induces adipogenesis in 3T3-L1 pre-adipocytes without peroxisome proliferator-activated receptor gamma
J Biol Chem
Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression
Blood
Bamboo extract reduces interleukin 6 (IL-6) overproduction under lipotoxic conditions through inhibiting the activation of NFkappaB and AP-1 pathways
Cytokine
Mulberry leaf ameliorates the expression profile of adipocytokines by inhibiting oxidative stress in white adipose tissue in db/db mice
Atherosclerosis
Dehydroabietic acid, a phytochemical, acts as ligand for PPARs in macrophages and adipocytes to regulate inflammation
Biochem Biophys Res Commun
Capsaicin, a spicy component of hot peppers, modulates adipokine gene expression and protein release from obese-mouse adipose tissues and isolated adipocytes, and suppresses the inflammatory responses of adipose tissue macrophages
FEBS Lett
Active spice-derived components can inhibit inflammatory responses of adipose tissue in obesity by suppressing inflammatory actions of macrophages and release of monocyte chemoattractant protein-1 from adipocytes
Life Sci
Grape-seed procyanidins modulate inflammation on human differentiated adipocytes in vitro
Cytokine
Anti-inflammatory effect of resveratrol on TNF-alpha-induced MCP-1 expression in adipocytes
Biochem Biophys Res Commun
L-cysteine supplementation lowers blood glucose, glycated hemoglobin, CRP, MCP-1, and oxidative stress and inhibits NF-kappaB activation in the livers of Zucker diabetic rats
Free Radic Biol Med
Peroxisome proliferator-activated receptor and retinoid X receptor ligands inhibit monocyte chemotactic protein-1-directed migration of monocytes
Eur J Pharmacol
The effect of low-dose atorvastatin on circulating monocyte chemoattractant protein-1 in patients with type 2 diabetes complicated by hyperlipidemia
Metabolism
Dilazep and fenofibric acid inhibit MCP-1 mRNA expression in glycoxidized LDL-stimulated human endothelial cells
Eur J Pharmacol
Angiotensin receptor blockers improve insulin resistance in type 2 diabetic rats by modulating adipose tissue
Kidney Int
Effect of atorvastatin on soluble CD14, CD40 Ligand, sE- and sP-selectins and MCP-1 in patients with type 2 diabetes mellitus: relationship to cholesterol turnover
Pharmacol Res
A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression
Biochem Bioph Res Comm
Monocyte chemoattractant protein 1–2518 A/G polymorphism and susceptibility to type 2 diabetes in a Chinese population
Clin Chim Acta
Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism as a potential risk factor for diabetic retinopathy in Japanese patients with type 2 diabetes
Diabetes Res Clin Pract
MCP-1 gene A-2518G polymorphism and carotid artery atherosclerosis in patients with type 2 diabetes
Diabetes Res Clin Pract
Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis
J Am Coll Cardiol
Relation of inflammatory chemokines to insulin resistance and hypoadiponectinemia in coronary artery disease patients
Eur J Intern Med
Association between circulating monocyte chemoattractant protein-1 and urinary albumin excretion in nonobese Type 2 diabetic patients
J Diabetes Complicat
J Am Coll Cardiol
Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line
J Exp Med
Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants
J Exp Med
Purification and amino acid analysis of two human monocyte chemoattractants produced by phytohemagglutinin-stimulated human blood mononuclear leukocytes
J Immunol
Complete amino acid sequence of a human monocyte chemoattractant, a putative mediator of cellular immune reactions
Proc Natl Acad Sci USA
Posttranslational modifications affect the activity of the human monocyte chemotactic proteins MCP-1 and MCP-2: identification of MCP-2(6–76) as a natural chemokine inhibitor
J Immunol
Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails
Proc Natl Acad Sci USA
Monocyte chemotactic and activating factor gene expression induced in endothelial cells by IL-1 and tumor necrosis factor
J Immunol
Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells
Proc Natl Acad Sci USA
Monocyte chemoattractant protein 1 in obesity and insulin resistance
Proc Natl Acad Sci USA
CC chemokine and CC chemokine receptor profiles in visceral and subcutaneous adipose tissue are altered in human obesity
J Clin Endocrinol Metab
Cited by (326)
Benzopyran hydrazones with dual PPARα/γ or PPARα/δ agonism and an anti-inflammatory effect on human THP-1 macrophages
2024, European Journal of Medicinal ChemistryCysLTR1 antagonism by montelukast can ameliorate diabetes-induced aortic and testicular inflammation
2023, International Immunopharmacology